Clinical Trials in Los Angeles

Showing 7861-7880 of 16,901 trials

A Treatment Use Protocol for Subjects Continuing on From the Open-label Extension 0601

NCT01002820

This study is designed to provide ganaxolone to those patients deriving significant benefit from current treatment in protocol 1042-0601.

Epilepsy, Complex Partial

Marinus Pharmaceuticals11 participantsStarted Oct 2009

Los Angeles, California, United States • Lexington, Kentucky, United States • Albany, New York, United States +4 more locations

COMPLETEDPhase 2< 1 mile

A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia

NCT04363736

This study will assess the pharmacodynamics, pharmacokinetics, safety and efficacy of two different doses of tocilizumab (TCZ) in combination with standard-of-care (SOC) in hospitalized adult participants with moderate to severe COVID-19 pneumonia.

COVID-19 Pneumonia

Hoffmann-La Roche97 participantsStarted May 2020

Phoenix, Arizona, United States • Fullerton, California, United States • Los Angeles, California, United States +21 more locations

A Treatment Use Protocol for Subjects Continuing on From the Open-label Extension 0601

A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia

Find Trials by Condition in Los Angeles

Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Participants With Presumed Nonalcoholic Steatohepatitis (NASH)

Subject Satisfaction With AbobutulinumtoxinA Treatment

A RCT of CenteringPregnancy on Birth Outcomes

Study to Evaluate the Safety and Tolerability of FX301 in Patients Undergoing Bunionectomy

Long-Term Safety of ARQ-151 Cream in Adult Subjects With Chronic Plaque Psoriasis

The Safety, Efficacy and Pharmacokinetics of ARQ-151 Cream in Subjects With Chronic Plaque Psoriasis

A Comparison Study of LY2140023 and Aripiprazole in Schizophrenia Patients

Efficacy and Safety of a New Dilution and Injection Volume of AbobotulinumtoxinA for the Treatment of Glabellar Lines

Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors

Study to Evaluate the Safety and Efficacy of SDP-4 in Subjects With Dry Eye Disease (DED)

A Study of LY2140023 in Schizophrenia Patients With Prominent Negative Symptoms

A Study of Mirikizumab (LY3074828) in Participants With Active Crohn's Disease

To Evaluate the Safety, and Pharmacokinetics of Parscaclisib in Participants With Normal Hepatic Function and Hepatic Impairment.

Safety and Efficacy Study of DUR-928 Topical Solution in Subjects With Plaque Psoriasis

Mentors Offering Maternal Support (M-O-M-S™): A Prenatal Program for Decreasing Maternal Anxiety and Depression

Long-term Follow-Up Study Following Treatment With Fate Therapeutics' Engineered Cellular Immunotherapy

An Exploratory, Open-Label, Oligo-Center Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravenous DNV3837 in Subjects With Clostridium Difficile Infection

A Prospective Study of Early Mechanical Stabilization and Bleeding in Disruption of the Pelvic Ring